Key statistics
On Friday, Dexcom Inc (DC4:DUS) closed at 62.78, 8.84% above its 52-week low of 57.68, set on Jul 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 63.99 |
---|---|
High | 63.99 |
Low | 62.78 |
Bid | 62.99 |
Offer | 63.20 |
Previous close | 64.07 |
Average volume | 311.00 |
---|---|
Shares outstanding | 400.73m |
Free float | 399.49m |
P/E (TTM) | 44.21 |
Market cap | 28.22bn USD |
EPS (TTM) | 1.59 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:32 BST.
More ▼
Press releases
- Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
- Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
- Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
- Dexcom Announces Upcoming Conference Presentation
- Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
- RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents
- Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
- Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
More ▼